title: Mixed chimerism and tolerance without whole body irradiation in a large animal model.
abstract: Mixed hematopoietic chimerism may provide a treatment for patients with nonmalignant hematologic diseases, and may tolerize patients to organ allografts without requiring chronic immunosuppression. However, the toxicity of the usual conditioning regimens has limited the clinical applicability of this approach. These regimens generally include some level of whole body irradiation (WBI), which is thought to facilitate engraftment either by making room for donor hematopoietic stem cells or by providing sufficient host immunosuppression to enable donor cells to engraft. Here, we have established mixed chimerism across both minor and major histocompatibility barriers in swine, by using high doses of peripheral blood stem cells in the absence of WBI. After mixed chimerism was established, swine leukocyte antigen-matched (SLA-matched) donor skin grafts were tolerated and maintained for a prolonged period, whereas third-party SLA-matched skin was rejected promptly. Donor-matched kidney allografts were also accepted without additional immunosuppression. Because of its low toxicity, this approach has potential for a wide range of clinical applications. Our data may indicate that niches for engrafting stem cells are filled by mass action and that WBI, which serves to empty some of these niches, can be omitted if the donor inoculum is sufficiently large and if adequate host T-cell depletion is achieved before transplant.
authors.affiliation: Transplantation Biology Research Center, and. Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA. Laboratory of Molecular Bi.
authors.forename: Y
authors.initials: Y
authors.lastname: Fuchimoto
authors.forename: C A
authors.initials: CA
authors.lastname: Huang
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: A
authors.initials: A
authors.lastname: Shimizu
authors.forename: H
authors.initials: H
authors.lastname: Kitamura
authors.forename: R B
authors.initials: RB
authors.lastname: Colvin
authors.forename: V
authors.initials: V
authors.lastname: Ferrara
authors.forename: M C
authors.initials: MC
authors.lastname: Murphy
authors.forename: M
authors.initials: M
authors.lastname: Sykes
authors.forename: M
authors.initials: M
authors.lastname: White-Scharf
authors.forename: D M
authors.initials: DM
authors.lastname: Neville
authors.forename: D H
authors.initials: DH
authors.lastname: Sachs
mesh_terms: D000818:Animals; D018380:Hematopoietic Stem Cell Transplantation; D007165:Immunosuppression Therapy / Q000379:methods*; D008212:Lymphocyte Depletion; D017713:Platelet Transfusion; D013552:Swine; D013556:Swine, Miniature; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology / Q000473:pathology / Q000528:radiation effects*; D018183:Transplantation Chimera; D014184:Transplantation, Homologous / Q000276:immunology*; D014916:Whole-Body Irradiation